BioCentury
ARTICLE | Finance

Alleviating lesions

What led Morgenthaler to back wound healing play Scioderm

April 29, 2013 7:00 AM UTC

Morgenthaler believes it has finally found a good entry point into wound healing via Scioderm LLC's $16 million series A round. The proceeds will fund a therapy to treat chronic wounds and lesions in children with epidermolysis bullosa.

Morgenthaler led last week's round, with participation from Technology Partners...